image
Basic Materials - Chemicals - Specialty - NYSE - US
$ 16.375
-1.95 %
$ 11.1 B
Market Cap
15.75
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one AVTR stock under the worst case scenario is HIDDEN Compared to the current market price of 16.4 USD, Avantor, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one AVTR stock under the base case scenario is HIDDEN Compared to the current market price of 16.4 USD, Avantor, Inc. is HIDDEN

This DCF valuation model was last updated on Mar, 2, 2025.

The intrinsic value of one AVTR stock under the best case scenario is HIDDEN Compared to the current market price of 16.4 USD, Avantor, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
6.78 B REVENUE
-2.64%
1.08 B OPERATING INCOME
55.77%
712 M NET INCOME
121.58%
841 M OPERATING CASH FLOW
-3.36%
439 M INVESTING CASH FLOW
405.43%
-1.28 B FINANCING CASH FLOW
-51.85%
1.69 B REVENUE
-1.62%
638 M OPERATING INCOME
412.12%
500 M NET INCOME
765.74%
173 M OPERATING CASH FLOW
-29.21%
558 M INVESTING CASH FLOW
1479.01%
-755 M FINANCING CASH FLOW
-280.31%
Balance Sheet Avantor, Inc.
image
Current Assets 2.15 B
Cash & Short-Term Investments 262 M
Receivables 1.03 B
Other Current Assets 850 M
Non-Current Assets 9.97 B
Long-Term Investments 0
PP&E 708 M
Other Non-Current Assets 9.26 B
Current Liabilities 2.01 B
Accounts Payable 663 M
Short-Term Debt 821 M
Other Current Liabilities 524 M
Non-Current Liabilities 4.15 B
Long-Term Debt 0
Other Non-Current Liabilities 4.15 B
EFFICIENCY
Earnings Waterfall Avantor, Inc.
image
Revenue 6.78 B
Cost Of Revenue 4.5 B
Gross Profit 2.28 B
Operating Expenses 1.19 B
Operating Income 1.08 B
Other Expenses 373 M
Net Income 712 M
RATIOS
33.60% GROSS MARGIN
33.60%
15.99% OPERATING MARGIN
15.99%
10.49% NET MARGIN
10.49%
11.94% ROE
11.94%
5.87% ROA
5.87%
8.27% ROIC
8.27%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Avantor, Inc.
image
Net Income 712 M
Depreciation & Amortization 406 M
Capital Expenditures -149 M
Stock-Based Compensation 46.8 M
Change in Working Capital 0
Others -276 M
Free Cash Flow 692 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Avantor, Inc.
image
Wall Street analysts predict an average 1-year price target for AVTR of $26.5 , with forecasts ranging from a low of $24.5 to a high of $28 .
AVTR Lowest Price Target Wall Street Target
24.5 USD 49.62%
AVTR Average Price Target Wall Street Target
26.5 USD 61.83%
AVTR Highest Price Target Wall Street Target
28 USD 70.99%
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Avantor, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
88.3 K USD 1
6-9 MONTHS
273 K USD 1
9-12 MONTHS
687 K USD 3
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
5 months ago
Sep 05, 2024
Sell 88.3 K USD
Eck Steven W
SVP & Chief Accounting Officer
- 3525
25.06 USD
7 months ago
Jul 30, 2024
Sell 270 K USD
Couturier Christophe
EVP, AMEA
- 10000
27 USD
7 months ago
Jul 31, 2024
Sell 2.8 K USD
Couturier Christophe
EVP, AMEA
- 100
28 USD
11 months ago
Mar 08, 2024
Sell 94.4 K USD
Eck Steven W
SVP & Chief Accounting Officer
- 3685
25.63 USD
1 year ago
Feb 29, 2024
Sell 120 K USD
Bramwell James
EVP Sales, Customer Excellence
- 4910
24.52 USD
1 year ago
Feb 29, 2024
Sell 321 K USD
Couturier Christophe
EVP, AMEA
- 13074
24.53 USD
1 year ago
Feb 27, 2024
Sell 152 K USD
Bramwell James
EVP Sales, Customer Excellence
- 6203
24.49 USD
1 year ago
Sep 07, 2023
Sell 156 K USD
Eck Steven W
SVP & Chief Accounting Officer
- 7577
20.64 USD
1 year ago
Aug 25, 2023
Sell 537 K USD
Vanderhaegen Frederic
EVP, Americas and Europe
- 25000
21.47 USD
1 year ago
Apr 11, 2023
Sell 31.7 K USD
Couturier Christophe
EVP, AMEA
- 1498
21.18 USD
2 years ago
Mar 03, 2023
Sell 97.8 K USD
Brophy Gerard
EVP, Biopharma Production
- 3914
25 USD
2 years ago
Feb 27, 2023
Sell 76.5 K USD
Brophy Gerard
EVP, Biopharma Production
- 3059
25 USD
2 years ago
Feb 28, 2023
Sell 56.5 K USD
Couturier Christophe
EVP, AMEA
- 2324
24.32 USD
2 years ago
Feb 23, 2023
Sell 74.6 K USD
Couturier Christophe
EVP, AMEA
- 3078
24.24 USD
2 years ago
Feb 22, 2023
Sell 462 K USD
Couturier Christophe
EVP, AMEA
- 19160
24.12 USD
2 years ago
Feb 02, 2023
Sell 284 K USD
Brophy Gerard
EVP, Biopharma Production
- 11339
25.06 USD
2 years ago
Nov 16, 2022
Bought 259 K USD
Szlosek Thomas A
EVP & CFO
+ 12500
20.708 USD
2 years ago
Nov 16, 2022
Bought 314 K USD
Stubblefield Michael
CEO
+ 15000
20.95 USD
2 years ago
May 20, 2022
Sell 613 K USD
Brophy Gerard
EVP, Biopharma Production
- 19603
31.27 USD
2 years ago
May 23, 2022
Sell 1.23 M USD
Vanderhaegen Frederic
EVP, Americas & Europe
- 39000
31.61 USD
3 years ago
Mar 01, 2022
Sell 69.9 K USD
Brophy Gerard
EVP, Biopharma Production
- 2027
34.47 USD
3 years ago
Feb 23, 2022
Sell 103 K USD
Brophy Gerard
EVP, Biopharma Production
- 3059
33.79 USD
3 years ago
Jan 03, 2022
Sell 2.42 M USD
Brophy Gerard
EVP, Biopharma Production
- 59418
40.77 USD
3 years ago
Jan 05, 2022
Sell 446 K USD
Brophy Gerard
EVP, Biopharma Production
- 11551
38.65 USD
3 years ago
Dec 27, 2021
Sell 424 K USD
Couturier Christophe
EVP, AMEA
- 10184
41.63 USD
3 years ago
Dec 21, 2021
Sell 1.57 M USD
Couturier Christophe
EVP, AMEA
- 38309
41 USD
3 years ago
Dec 22, 2021
Sell 1.17 M USD
Couturier Christophe
EVP, AMEA
- 28125
41.53 USD
3 years ago
Dec 08, 2021
Sell 233 K USD
Couturier Christophe
EVP, AMEA
- 5828
40 USD
3 years ago
Dec 09, 2021
Sell 316 K USD
Couturier Christophe
EVP, AMEA
- 7859
40.24 USD
3 years ago
Dec 01, 2021
Sell 3.93 M USD
GUPTA RAJIV
Director
- 100000
39.3 USD
3 years ago
Nov 11, 2021
Sell 2.34 M USD
Vanderhaegen Frederic
EVP, Europe
- 60804
38.41 USD
3 years ago
Nov 12, 2021
Sell 3.06 M USD
Vanderhaegen Frederic
EVP, Europe
- 80000
38.25 USD
3 years ago
Nov 01, 2021
Sell 4.03 M USD
GUPTA RAJIV
Director
- 100000
40.31 USD
3 years ago
Oct 01, 2021
Sell 3.99 M USD
GUPTA RAJIV
Director
- 100000
39.94 USD
3 years ago
Sep 20, 2021
Sell 5.99 M USD
Stubblefield Michael
President and CEO
- 141300
42.37 USD
3 years ago
Sep 01, 2021
Sell 3.95 M USD
GUPTA RAJIV
Director
- 100000
39.45 USD
3 years ago
Aug 26, 2021
Sell 697 K USD
Eck Steven W
SVP & Chief Accounting Officer
- 17383
40.08 USD
3 years ago
Aug 20, 2021
Sell 3.88 M USD
GUPTA RAJIV
Director
- 100000
38.81 USD
3 years ago
Jul 12, 2021
Bought 10.9 K USD
Natauri Jo
Director
+ 300
36.334 USD
3 years ago
Jul 30, 2021
Sell 3.02 M USD
Brophy Gerard
EVP, Biopharma Production
- 81125
37.24 USD
3 years ago
Jul 20, 2021
Sell 226 K USD
Bramwell James
EVP, Strategic Partners
- 6112
37 USD
3 years ago
Jul 09, 2021
Sell 217 K USD
Bramwell James
EVP, Strategic Partners
- 6110
35.56 USD
3 years ago
Jul 09, 2021
Sell 436 K USD
Bramwell James
EVP, Strategic Partners
- 12221
35.64 USD
3 years ago
Jun 28, 2021
Sell 1 M USD
Couturier Christophe
EVP, AMEA
- 28096
35.73 USD
3 years ago
Jun 25, 2021
Sell 2.42 M USD
GUPTA RAJIV
Director
- 68605
35.32 USD
3 years ago
Jun 08, 2021
Sell 4.89 M USD
Stubblefield Michael
President and CEO
- 152643
32.04 USD
3 years ago
Jun 09, 2021
Sell 7.53 M USD
Stubblefield Michael
President and CEO
- 235170
32.03 USD
3 years ago
Jun 10, 2021
Sell 1.86 M USD
Stubblefield Michael
President and CEO
- 57375
32.48 USD
3 years ago
May 26, 2021
Sell 4.78 M USD
GUPTA RAJIV
Director
- 150000
31.89 USD
3 years ago
May 27, 2021
Sell 2.49 M USD
GUPTA RAJIV
Director
- 78109
31.94 USD
3 years ago
May 27, 2021
Sell 3.2 M USD
Ohri Devashish
EVP, IMEA
- 100000
31.99 USD
3 years ago
May 26, 2021
Sell 478 K USD
Ohri Devashish
EVP, IMEA
- 15000
31.87 USD
3 years ago
May 24, 2021
Sell 5.71 M USD
GUPTA RAJIV
Director
- 180000
31.74 USD
3 years ago
May 24, 2021
Sell 4.97 M USD
GUPTA RAJIV
Director
- 157571
31.57 USD
3 years ago
May 24, 2021
Sell 290 K USD
Ohri Devashish
EVP, IMEA
- 9124
31.75 USD
3 years ago
May 21, 2021
Sell 581 K USD
Wondrasch Michael
EVP & CIO
- 18488
31.41 USD
3 years ago
May 20, 2021
Sell 575 K USD
Miller Justin
EVP & General Counsel
- 18488
31.12 USD
3 years ago
May 20, 2021
Sell 779 K USD
Couturier Christophe
EVP, AMEA
- 25010
31.13 USD
3 years ago
May 20, 2021
Sell 610 K USD
Brophy Gerard
EVP, Biopharma Production
- 19603
31.1 USD
3 years ago
May 11, 2021
Sell 80.6 M USD
Natauri Jo
Director
- 2626771
30.68 USD
5 years ago
Sep 09, 2019
Bought 2.46 M USD
Natauri Jo
Director
+ 149694
16.4566 USD
5 years ago
Sep 06, 2019
Bought 1.11 M USD
Natauri Jo
Director
+ 67437
16.5133 USD
5 years ago
Sep 06, 2019
Bought 840 K USD
Natauri Jo
Director
+ 49200
17.0639 USD
5 years ago
Aug 12, 2019
Bought 268 K USD
Natauri Jo
Director
+ 16245
16.5133 USD
5 years ago
Sep 25, 2019
Bought 147 K USD
Natauri Jo
Director
+ 9922
14.8 USD
5 years ago
Sep 25, 2019
Bought 76.4 K USD
Natauri Jo
Director
+ 5164
14.79 USD
5 years ago
Sep 25, 2019
Bought 61.2 K USD
Natauri Jo
Director
+ 4146
14.76 USD
5 years ago
Sep 25, 2019
Bought 56.2 K USD
Natauri Jo
Director
+ 3800
14.78 USD
5 years ago
Sep 09, 2019
Sell 2.46 M USD
Natauri Jo
Director
- 149694
16.4566 USD
5 years ago
Sep 25, 2019
Bought 26 K USD
Natauri Jo
Director
+ 1768
14.7 USD
5 years ago
Sep 25, 2019
Bought 1.48 K USD
Natauri Jo
Director
+ 100
14.785 USD
5 years ago
Sep 25, 2019
Bought 1.48 K USD
Natauri Jo
Director
+ 100
14.775 USD
5 years ago
Sep 25, 2019
Sell 147 K USD
Natauri Jo
Director
- 9922
14.8 USD
5 years ago
Sep 25, 2019
Sell 26 K USD
Natauri Jo
Director
- 1768
14.7 USD
5 years ago
Sep 25, 2019
Sell 61.2 K USD
Natauri Jo
Director
- 4146
14.76 USD
5 years ago
Sep 25, 2019
Sell 1.48 K USD
Natauri Jo
Director
- 100
14.775 USD
5 years ago
Sep 25, 2019
Sell 56.2 K USD
Natauri Jo
Director
- 3800
14.78 USD
5 years ago
Sep 25, 2019
Sell 1.48 K USD
Natauri Jo
Director
- 100
14.785 USD
5 years ago
Sep 25, 2019
Sell 76.4 K USD
Natauri Jo
Director
- 5164
14.79 USD
5 years ago
Aug 12, 2019
Bought 150 USD
Natauri Jo
Director
+ 9
16.66 USD
5 years ago
Aug 12, 2019
Sell 268 K USD
Natauri Jo
Director
- 16245
16.5133 USD
5 years ago
Aug 12, 2019
Sell 150 USD
Natauri Jo
Director
- 9
16.66 USD
5 years ago
Sep 06, 2019
Sell 840 K USD
Natauri Jo
Director
- 49200
17.0639 USD
5 years ago
Sep 06, 2019
Sell 1.11 M USD
Natauri Jo
Director
- 67437
16.5133 USD
5 years ago
Aug 06, 2019
Bought 1.47 K USD
Natauri Jo
Director
+ 88
16.66 USD
5 years ago
Aug 06, 2019
Sell 1.47 K USD
Natauri Jo
Director
- 88
16.66 USD
5 years ago
Jul 31, 2019
Bought 965 USD
Natauri Jo
Director
+ 55
17.5476 USD
5 years ago
Jul 31, 2019
Sell 965 USD
Natauri Jo
Director
- 55
17.5476 USD
5 years ago
May 17, 2019
Bought 183 K USD
Natauri Jo
Director
+ 13099
14 USD
5 years ago
May 17, 2019
Sell 197 K USD
Natauri Jo
Director
- 14049
14 USD
5 years ago
Sep 09, 2019
Bought 2.46 M USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 149694
16.4566 USD
5 years ago
Sep 06, 2019
Bought 1.11 M USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 67437
16.5133 USD
5 years ago
Sep 06, 2019
Bought 840 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 49200
17.0639 USD
5 years ago
Aug 12, 2019
Bought 268 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 16245
16.5133 USD
5 years ago
Sep 25, 2019
Bought 147 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 9922
14.8 USD
5 years ago
Sep 25, 2019
Bought 76.4 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 5164
14.79 USD
5 years ago
Sep 25, 2019
Bought 61.2 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 4146
14.76 USD
5 years ago
Sep 25, 2019
Bought 56.2 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 3800
14.78 USD
5 years ago
Sep 09, 2019
Sell 2.46 M USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 149694
16.4566 USD
5 years ago
Sep 25, 2019
Bought 26 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 1768
14.7 USD
5 years ago
Sep 25, 2019
Bought 1.48 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 100
14.785 USD
5 years ago
Sep 25, 2019
Bought 1.48 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 100
14.775 USD
5 years ago
Sep 25, 2019
Sell 61.2 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 4146
14.76 USD
5 years ago
Sep 25, 2019
Sell 1.48 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 100
14.775 USD
5 years ago
Sep 25, 2019
Sell 1.48 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 100
14.785 USD
5 years ago
Sep 25, 2019
Sell 56.2 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 3800
14.78 USD
5 years ago
Sep 25, 2019
Sell 147 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 9922
14.8 USD
5 years ago
Sep 25, 2019
Sell 26 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 1768
14.7 USD
5 years ago
Sep 25, 2019
Sell 76.4 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 5164
14.79 USD
5 years ago
Aug 12, 2019
Bought 150 USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 9
16.66 USD
5 years ago
Aug 12, 2019
Sell 150 USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 9
16.66 USD
5 years ago
Aug 12, 2019
Sell 268 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 16245
16.5133 USD
5 years ago
Sep 06, 2019
Sell 840 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 49200
17.0639 USD
5 years ago
Sep 06, 2019
Sell 1.11 M USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 67437
16.5133 USD
5 years ago
Aug 06, 2019
Bought 1.47 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 88
16.66 USD
5 years ago
Aug 06, 2019
Sell 1.47 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 88
16.66 USD
5 years ago
Jul 31, 2019
Bought 965 USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 55
17.5476 USD
5 years ago
Jul 31, 2019
Sell 965 USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 55
17.5476 USD
5 years ago
May 17, 2019
Bought 183 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 13099
14 USD
5 years ago
May 17, 2019
Sell 197 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 14049
14 USD
5 years ago
Sep 09, 2019
Bought 2.46 M USD
Connolly Thomas
Director
+ 149694
16.4566 USD
5 years ago
Sep 06, 2019
Bought 1.11 M USD
Connolly Thomas
Director
+ 67437
16.5133 USD
5 years ago
Sep 06, 2019
Bought 840 K USD
Connolly Thomas
Director
+ 49200
17.0639 USD
5 years ago
Aug 12, 2019
Bought 268 K USD
Connolly Thomas
Director
+ 16245
16.5133 USD
5 years ago
Sep 25, 2019
Bought 147 K USD
Connolly Thomas
Director
+ 9922
14.8 USD
5 years ago
Sep 25, 2019
Bought 76.4 K USD
Connolly Thomas
Director
+ 5164
14.79 USD
5 years ago
Sep 25, 2019
Bought 61.2 K USD
Connolly Thomas
Director
+ 4146
14.76 USD
5 years ago
Sep 25, 2019
Bought 56.2 K USD
Connolly Thomas
Director
+ 3800
14.78 USD
5 years ago
Sep 09, 2019
Sell 2.46 M USD
Connolly Thomas
Director
- 149694
16.4566 USD
5 years ago
Sep 25, 2019
Bought 26 K USD
Connolly Thomas
Director
+ 1768
14.7 USD
5 years ago
Sep 25, 2019
Bought 1.48 K USD
Connolly Thomas
Director
+ 100
14.785 USD
5 years ago
Sep 25, 2019
Bought 1.48 K USD
Connolly Thomas
Director
+ 100
14.775 USD
5 years ago
Sep 25, 2019
Sell 26 K USD
Connolly Thomas
Director
- 1768
14.7 USD
5 years ago
Sep 25, 2019
Sell 61.2 K USD
Connolly Thomas
Director
- 4146
14.76 USD
5 years ago
Sep 25, 2019
Sell 1.48 K USD
Connolly Thomas
Director
- 100
14.775 USD
5 years ago
Sep 25, 2019
Sell 56.2 K USD
Connolly Thomas
Director
- 3800
14.78 USD
5 years ago
Sep 25, 2019
Sell 1.48 K USD
Connolly Thomas
Director
- 100
14.785 USD
5 years ago
Sep 25, 2019
Sell 76.4 K USD
Connolly Thomas
Director
- 5164
14.79 USD
5 years ago
Sep 25, 2019
Sell 147 K USD
Connolly Thomas
Director
- 9922
14.8 USD
5 years ago
Aug 12, 2019
Bought 150 USD
Connolly Thomas
Director
+ 9
16.66 USD
5 years ago
Aug 12, 2019
Sell 150 USD
Connolly Thomas
Director
- 9
16.66 USD
5 years ago
Aug 12, 2019
Sell 268 K USD
Connolly Thomas
Director
- 16245
16.5133 USD
5 years ago
Sep 06, 2019
Sell 840 K USD
Connolly Thomas
Director
- 49200
17.0639 USD
5 years ago
Sep 06, 2019
Sell 1.11 M USD
Connolly Thomas
Director
- 67437
16.5133 USD
5 years ago
Aug 06, 2019
Bought 1.47 K USD
Connolly Thomas
Director
+ 88
16.66 USD
5 years ago
Aug 06, 2019
Sell 1.47 K USD
Connolly Thomas
Director
- 88
16.66 USD
5 years ago
Jul 31, 2019
Bought 965 USD
Connolly Thomas
Director
+ 55
17.5476 USD
5 years ago
Jul 31, 2019
Sell 965 USD
Connolly Thomas
Director
- 55
17.5476 USD
5 years ago
May 17, 2019
Bought 183 K USD
Connolly Thomas
Director
+ 13099
14 USD
5 years ago
May 17, 2019
Sell 197 K USD
Connolly Thomas
Director
- 14049
14 USD
4 years ago
Jun 18, 2020
Bought 10.8 K USD
Connolly Thomas
Director
+ 630
17.18 USD
4 years ago
Jun 18, 2020
Sell 10.8 K USD
Connolly Thomas
Director
- 630
17.18 USD
3 years ago
Apr 30, 2021
Sell 1.75 M USD
Ohri Devashish
EVP, IMEA
- 53649
32.58 USD
3 years ago
Apr 12, 2021
Sell 3.24 M USD
Ohri Devashish
EVP, IMEA
- 100160
32.37 USD
3 years ago
Apr 12, 2021
Sell 318 K USD
Vanderhaegen Frederic
EVP, Europe
- 10000
31.75 USD
3 years ago
Apr 12, 2021
Sell 543 K USD
Vanderhaegen Frederic
EVP, Europe
- 17075
31.83 USD
3 years ago
Apr 12, 2021
Sell 80.2 K USD
Bramwell James
EVP, Strategic Partners
- 2505
32 USD
3 years ago
Apr 12, 2021
Sell 91.9 K USD
Miller Justin
EVP & General Counsel
- 2895
31.75 USD
3 years ago
Apr 12, 2021
Sell 3.32 M USD
Miller Justin
EVP & General Counsel
- 100000
33.21 USD
3 years ago
Mar 09, 2021
Sell 282 K USD
Vanderhaegen Frederic
EVP, Europe
- 10000
28.21 USD
4 years ago
Mar 02, 2021
Sell 87.2 K USD
Wondrasch Michael
EVP & CIO
- 3036
28.71 USD
4 years ago
Feb 24, 2021
Sell 85.4 K USD
Brophy Gerard
EVP, Biopharma Production
- 3059
27.93 USD
4 years ago
Feb 22, 2021
Sell 566 K USD
Brophy Gerard
EVP, Biopharma Production
- 19769
28.62 USD
4 years ago
Feb 05, 2021
Sell 1.19 M USD
Wondrasch Michael
EVP & CIO
- 40000
29.77 USD
4 years ago
Jan 11, 2021
Sell 75.2 K USD
Bramwell James
EVP, Strategic Partners
- 2505
30 USD
4 years ago
Jan 11, 2021
Sell 6.51 M USD
Brophy Gerard
EVP, Biopharma Production
- 216332
30.08 USD
4 years ago
Jan 11, 2021
Sell 4.87 M USD
Brophy Gerard
EVP, Biopharma Production
- 162248
30.04 USD
4 years ago
Jan 06, 2021
Sell 314 K USD
Brophy Gerard
EVP, Biopharma Production
- 11509
27.24 USD
4 years ago
Jan 04, 2021
Sell 1.65 M USD
Brophy Gerard
EVP, Biopharma Production
- 59418
27.84 USD
4 years ago
Dec 21, 2020
Sell 272 K USD
Bramwell James
EVP, Strategic Partners
- 10020
27.14 USD
4 years ago
Dec 11, 2020
Sell 381 K USD
Shaw Christi
Director
- 14286
26.68 USD
4 years ago
Dec 07, 2020
Sell 2.7 M USD
Stubblefield Michael
President and CEO
- 98452
27.45 USD
4 years ago
Dec 04, 2020
Sell 11.2 M USD
Stubblefield Michael
President and CEO
- 412188
27.08 USD
4 years ago
Jun 30, 2020
Bought 6.8 K USD
Natauri Jo
Director
+ 400
17 USD
4 years ago
Jul 01, 2020
Bought 11 K USD
Natauri Jo
Director
+ 646
16.99 USD
4 years ago
Jun 30, 2020
Bought 9.99 K USD
Natauri Jo
Director
+ 584
17.1 USD
4 years ago
Jun 30, 2020
Bought 32.7 K USD
Natauri Jo
Director
+ 1910
17.1 USD
4 years ago
Jun 30, 2020
Sell 6.8 K USD
Natauri Jo
Director
- 400
17 USD
4 years ago
Jun 30, 2020
Bought 961 USD
Natauri Jo
Director
+ 56
17.16 USD
4 years ago
Jun 30, 2020
Bought 18.9 K USD
Natauri Jo
Director
+ 1103
17.1 USD
4 years ago
Jun 11, 2020
Bought 34.8 K USD
Natauri Jo
Director
+ 2055
16.92 USD
4 years ago
Jun 30, 2020
Sell 62.5 K USD
Natauri Jo
Director
- 3653
17.1 USD
4 years ago
Jun 25, 2020
Bought 2.54 K USD
Natauri Jo
Director
+ 151
16.84 USD
4 years ago
Jun 25, 2020
Sell 2.54 K USD
Natauri Jo
Director
- 151
16.84 USD
4 years ago
Jun 23, 2020
Bought 5.32 K USD
Natauri Jo
Director
+ 300
17.75 USD
4 years ago
Jun 19, 2020
Bought 35.9 USD
Natauri Jo
Director
+ 2
17.95 USD
4 years ago
Jun 19, 2020
Sell 35.9 USD
Natauri Jo
Director
- 2
17.95 USD
4 years ago
Jun 22, 2020
Bought 504 USD
Natauri Jo
Director
+ 29
17.38 USD
4 years ago
Jun 18, 2020
Bought 119 K USD
Natauri Jo
Director
+ 6798
17.51 USD
4 years ago
Jun 22, 2020
Sell 504 USD
Natauri Jo
Director
- 29
17.38 USD
4 years ago
Jun 23, 2020
Sell 5.32 K USD
Natauri Jo
Director
- 300
17.75 USD
4 years ago
Jun 26, 2020
Bought 336 USD
Natauri Jo
Director
+ 20
16.82 USD
4 years ago
Jun 26, 2020
Sell 336 USD
Natauri Jo
Director
- 20
16.82 USD
4 years ago
Jun 12, 2020
Bought 5.09 K USD
Natauri Jo
Director
+ 300
16.98 USD
4 years ago
Jun 11, 2020
Sell 34.8 K USD
Natauri Jo
Director
- 2055
16.92 USD
4 years ago
Jun 12, 2020
Sell 5.09 K USD
Natauri Jo
Director
- 300
16.98 USD
4 years ago
Jul 01, 2020
Bought 5.9 K USD
Natauri Jo
Director
+ 347
16.99 USD
4 years ago
Jul 01, 2020
Bought 7.41 K USD
Natauri Jo
Director
+ 436
16.99 USD
4 years ago
Jul 01, 2020
Sell 170 K USD
Natauri Jo
Director
- 10000
17 USD
4 years ago
Jun 18, 2020
Sell 119 K USD
Natauri Jo
Director
- 6798
17.51 USD
4 years ago
Jul 01, 2020
Sell 34.1 K USD
Natauri Jo
Director
- 2006
16.99 USD
4 years ago
Jul 01, 2020
Bought 1.05 K USD
Natauri Jo
Director
+ 62
16.99 USD
4 years ago
Jul 01, 2020
Sell 229 K USD
Natauri Jo
Director
- 13404
17.09 USD
4 years ago
Jun 18, 2020
Bought 10.8 K USD
Natauri Jo
Director
+ 630
17.18 USD
4 years ago
Jun 18, 2020
Sell 10.8 K USD
Natauri Jo
Director
- 630
17.18 USD
4 years ago
Jun 30, 2020
Bought 6.8 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 400
17 USD
4 years ago
Jul 01, 2020
Bought 11 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 646
16.99 USD
4 years ago
Jun 30, 2020
Bought 9.99 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 584
17.1 USD
4 years ago
Jun 30, 2020
Bought 32.7 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 1910
17.1 USD
4 years ago
Jun 30, 2020
Sell 6.8 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 400
17 USD
4 years ago
Jun 30, 2020
Bought 961 USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 56
17.16 USD
4 years ago
Jun 30, 2020
Bought 18.9 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 1103
17.1 USD
4 years ago
Jun 11, 2020
Bought 34.8 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 2055
16.92 USD
4 years ago
Jun 30, 2020
Sell 62.5 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 3653
17.1 USD
4 years ago
Jun 25, 2020
Bought 2.54 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 151
16.84 USD
4 years ago
Jun 25, 2020
Sell 2.54 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 151
16.84 USD
4 years ago
Jun 23, 2020
Bought 5.32 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 300
17.75 USD
4 years ago
Jun 19, 2020
Bought 35.9 USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 2
17.95 USD
4 years ago
Jun 19, 2020
Sell 35.9 USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 2
17.95 USD
4 years ago
Jun 22, 2020
Bought 504 USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 29
17.38 USD
4 years ago
Jun 18, 2020
Bought 119 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 6798
17.51 USD
4 years ago
Jun 22, 2020
Sell 504 USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 29
17.38 USD
4 years ago
Jun 23, 2020
Sell 5.32 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 300
17.75 USD
4 years ago
Jun 26, 2020
Bought 336 USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 20
16.82 USD
4 years ago
Jun 26, 2020
Sell 336 USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 20
16.82 USD
4 years ago
Jun 12, 2020
Bought 5.09 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 300
16.98 USD
4 years ago
Jun 11, 2020
Sell 34.8 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 2055
16.92 USD
4 years ago
Jun 12, 2020
Sell 5.09 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 300
16.98 USD
4 years ago
Jul 01, 2020
Bought 5.9 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 347
16.99 USD
4 years ago
Jul 01, 2020
Bought 7.41 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 436
16.99 USD
4 years ago
Jul 01, 2020
Sell 170 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 10000
17 USD
4 years ago
Jun 18, 2020
Sell 119 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 6798
17.51 USD
4 years ago
Jul 01, 2020
Sell 34.1 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 2006
16.99 USD
4 years ago
Jul 01, 2020
Bought 1.05 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 62
16.99 USD
4 years ago
Jul 01, 2020
Sell 229 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 13404
17.09 USD
4 years ago
Jun 18, 2020
Bought 10.8 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
+ 630
17.18 USD
4 years ago
Jun 18, 2020
Sell 10.8 K USD
GOLDMAN SACHS & CO. LLC
10 percent owner
- 630
17.18 USD
4 years ago
Nov 10, 2020
Sell 893 M USD
New Mountain Investments III, LLC
10 percent owner
- 36016093
24.8081 USD
4 years ago
Oct 05, 2020
Sell 434 K USD
Ohri Devashish
EVP, IMEA
- 18440
23.53 USD
4 years ago
Oct 05, 2020
Sell 821 K USD
Ohri Devashish
EVP, IMEA
- 35000
23.47 USD
4 years ago
Oct 05, 2020
Sell 1.17 M USD
Ohri Devashish
EVP, IMEA
- 50000
23.34 USD
4 years ago
Sep 16, 2020
Sell 806 K USD
Ohri Devashish
EVP, IMEA
- 35000
23.02 USD
4 years ago
Sep 08, 2020
Sell 485 K USD
Miller Justin
EVP & General Counsel
- 22887
21.17 USD
4 years ago
Aug 21, 2020
Sell 300 M USD
Natauri Jo
- 15397005
19.5065 USD
4 years ago
Aug 21, 2020
Sell 300 M USD
GOLDMAN SACHS & CO. LLC
- 15397005
19.5065 USD
4 years ago
Aug 21, 2020
Sell 499 M USD
New Mountain Investments III, LLC
10 percent owner
- 25575472
19.5065 USD
4 years ago
Jul 30, 2020
Sell 748 K USD
Ohri Devashish
EVP, IMEA
- 35000
21.37 USD
4 years ago
May 29, 2020
Sell 557 K USD
Ohri Devashish
EVP, IMEA
- 30000
18.57 USD
4 years ago
May 29, 2020
Sell 667 K USD
Ohri Devashish
EVP, IMEA
- 35000
19.07 USD
4 years ago
May 26, 2020
Sell 332 M USD
New Mountain Investments III, LLC
10 percent owner
- 20886424
15.9047 USD
4 years ago
May 26, 2020
Sell 218 M USD
Natauri Jo
- 13726411
15.9 USD
4 years ago
May 26, 2020
Sell 218 M USD
Connolly Thomas
- 13726411
15.9 USD
4 years ago
May 26, 2020
Sell 218 M USD
GOLDMAN SACHS & CO. LLC
- 13726411
15.9 USD
4 years ago
May 22, 2020
Sell 410 K USD
Wondrasch Michael
EVP & CIO
- 22987
17.82 USD
4 years ago
May 20, 2020
Sell 443 K USD
Brophy Gerard
EVP, Biopharma Production
- 25495
17.36 USD
5 years ago
Feb 18, 2020
Sell 351 K USD
Ohri Devashish
EVP, IMEA
- 20000
17.54 USD
5 years ago
May 21, 2019
Sell 1.4 K USD
New Mountain Investments III, LLC
10 percent owner
- 100
14 USD
13 years ago
May 20, 2011
Sell 436 K USD
KELFER GERALD D
President & CEO
- 27000
16.158 USD
13 years ago
May 18, 2011
Sell 495 K USD
KELFER GERALD D
President & CEO
- 30000
16.509 USD
13 years ago
May 17, 2011
Bought 82.4 K USD
DONNELL JON M
PRESIDENT AND CEO
+ 5000
16.4833 USD
13 years ago
May 16, 2011
Sell 408 K USD
KELFER GERALD D
President & CEO
- 24156
16.883 USD
13 years ago
May 17, 2011
Sell 631 K USD
KELFER GERALD D
President & CEO
- 38844
16.238 USD
14 years ago
Nov 29, 2010
Sell 245 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
- 12876
19.03 USD
14 years ago
Nov 15, 2010
Sell 245 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
- 12876
19.03 USD
14 years ago
Nov 12, 2010
Sell 344 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
- 17875
19.242 USD
14 years ago
Nov 15, 2010
Sell 304 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
- 16000
19.021 USD
14 years ago
Aug 27, 2010
Sell 3.53 K USD
RAMA MICHAEL P
Controller
- 200
17.64 USD
14 years ago
Aug 27, 2010
Sell 14.6 K USD
RAMA MICHAEL P
Controller
- 831
17.6 USD
14 years ago
Mar 24, 2010
Sell 75.8 K USD
FELS JONATHAN
other: Ex-Pres. Avatar Properties
- 3762
20.16 USD
14 years ago
Mar 22, 2010
Sell 312 K USD
FELS JONATHAN
other: Ex-Pres. Avatar Properties
- 16000
19.52 USD
14 years ago
Mar 23, 2010
Sell 404 K USD
FELS JONATHAN
other: Ex-Pres. Avatar Properties
- 20238
19.98 USD
16 years ago
Mar 24, 2008
Sell 0 USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
- 4196
0 USD
16 years ago
Mar 24, 2008
Sell 0 USD
FELS JONATHAN
President Avatar Properties
- 26123
0 USD
16 years ago
Mar 20, 2008
Sell 0 USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
- 40804
0 USD
16 years ago
Mar 20, 2008
Sell 0 USD
KELFER GERALD D
President & CEO
- 50000
0 USD
16 years ago
Mar 20, 2008
Sell 0 USD
FELS JONATHAN
President Avatar Properties
- 18877
0 USD
17 years ago
Apr 05, 2007
Sell 0 USD
FELS JONATHAN
President Avatar Properties
- 4000
0 USD
17 years ago
Apr 03, 2007
Sell 0 USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
- 20000
0 USD
17 years ago
Mar 30, 2007
Sell 0 USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
- 10000
0 USD
17 years ago
Mar 30, 2007
Sell 0 USD
FELS JONATHAN
President Avatar Properties
- 14500
0 USD
17 years ago
Mar 27, 2007
Sell 0 USD
KELFER GERALD D
President & CEO
- 13447
0 USD
17 years ago
Mar 27, 2007
Sell 21.3 K USD
FELS JONATHAN
President Avatar Properties
- 300
71.1 USD
17 years ago
Mar 27, 2007
Sell 14.2 K USD
FELS JONATHAN
President Avatar Properties
- 200
71.11 USD
17 years ago
Mar 27, 2007
Sell 21.3 K USD
FELS JONATHAN
President Avatar Properties
- 300
71.15 USD
17 years ago
Mar 27, 2007
Sell 49.7 K USD
FELS JONATHAN
President Avatar Properties
- 700
71.06 USD
17 years ago
Mar 26, 2007
Sell 36.4 K USD
FELS JONATHAN
President Avatar Properties
- 500
72.75 USD
17 years ago
Mar 23, 2007
Sell 0 USD
KELFER GERALD D
President & CEO
- 8000
0 USD
17 years ago
Mar 26, 2007
Sell 0 USD
KELFER GERALD D
President & CEO
- 10500
0 USD
17 years ago
Mar 21, 2007
Sell 0 USD
KELFER GERALD D
President & CEO
- 17733
0 USD
17 years ago
Mar 22, 2007
Sell 0 USD
KELFER GERALD D
President & CEO
- 10320
0 USD
17 years ago
Mar 21, 2007
Sell 0 USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
- 13014
0 USD
17 years ago
Mar 22, 2007
Sell 0 USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
- 6986
0 USD
17 years ago
Mar 22, 2007
Sell 0 USD
GETMAN DENNIS J
EVP
- 8024
0 USD
17 years ago
Mar 23, 2007
Sell 0 USD
GETMAN DENNIS J
EVP
- 2991
0 USD
17 years ago
Mar 22, 2007
Sell 0 USD
FELS JONATHAN
President Avatar Properties
- 800
0 USD
19 years ago
Aug 12, 2005
Bought 0 USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
+ 0
52.63 USD
19 years ago
Mar 31, 2005
Bought 92.8 K USD
LEVY MICHAEL F
EVP & COO Avatar Properties
+ 2000
46.4 USD
19 years ago
Mar 30, 2005
Bought 94.2 K USD
KELFER GERALD D
President & CEO
+ 2000
47.1 USD
19 years ago
Mar 21, 2005
Bought 19.4 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
+ 400
48.42 USD
19 years ago
Mar 21, 2005
Bought 13.5 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
+ 278
48.41 USD
19 years ago
Mar 21, 2005
Bought 10.8 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
+ 223
48.4 USD
19 years ago
Mar 21, 2005
Bought 4.79 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
+ 99
48.39 USD
19 years ago
Mar 21, 2005
Bought 15.7 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
+ 323
48.53 USD
19 years ago
Mar 21, 2005
Bought 3.74 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
+ 77
48.51 USD
19 years ago
Mar 21, 2005
Bought 4.85 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
+ 100
48.52 USD
19 years ago
Mar 21, 2005
Bought 19.4 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
+ 400
48.45 USD
19 years ago
Mar 21, 2005
Bought 4.84 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
+ 100
48.42 USD
19 years ago
Mar 21, 2005
Bought 24.2 K USD
LEVY MICHAEL F
EVP & COO, Avatar Properties
+ 500
48.3 USD
20 years ago
Sep 30, 2004
Bought 19.6 K USD
STEWART BETH
Director
+ 460
42.63 USD
20 years ago
Sep 30, 2004
Bought 10.2 K USD
STEWART BETH
Director
+ 240
42.62 USD
20 years ago
Sep 30, 2004
Bought 17 K USD
STEWART BETH
Director
+ 400
42.61 USD
20 years ago
Sep 30, 2004
Bought 12.8 K USD
STEWART BETH
Director
+ 300
42.6 USD
20 years ago
Sep 30, 2004
Bought 8.52 K USD
STEWART BETH
Director
+ 200
42.58 USD
20 years ago
Sep 30, 2004
Bought 17 K USD
STEWART BETH
Director
+ 400
42.55 USD
20 years ago
Mar 29, 2004
Bought 114 K USD
STEWART BETH
Director
+ 3000
37.95 USD
21 years ago
Sep 11, 2003
Bought 96.8 K USD
STEWART BETH
Director
+ 3000
32.28 USD
7. News
Avantor® to Present at TD Cowen's 45th Annual Health Care Conference RADNOR, Pa. , Feb. 19, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that President and CEO, Michael Stubblefield, will present at TD Cowen's 45th Annual Health Care Conference on Wednesday, March 5, at 11:50 a.m. prnewswire.com - 1 week ago
Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq's Novel Surface Treatment Technology SUNNY ISLES BEACH, Fla.--(BUSINESS WIRE)--Silq Technologies Corporation, a privately held advanced materials science company, and NuSil Technology LLC, a subsidiary of Avantor Inc., Radnor, Pa. (NYSE: AVTR), and a leading global supplier of high-quality silicones for long-term medical implants, have entered into an agreement to facilitate the utilization of Silq's zwitterionic surface treatment technology on medical devices manufactured with NuSil silicone products. Zwitterion surface technolog. businesswire.com - 1 week ago
Avantor Stock Declines Despite Q4 Earnings Beat, Margins Expand Despite AVTR's stability in proprietary chemicals and specialty procurement sales, it reports an overall soft fourth-quarter performance. zacks.com - 3 weeks ago
Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript Avantor, Inc. (NYSE:AVTR ) Q4 2024 Earnings Conference Call February 7, 2025 8:00 AM ET Company Participants Allison Hosak - SVP of Global Communications Michael Stubblefield - President and CEO Brent Jones - EVP and CFO Conference Call Participants Vijay Kumar - Evercore ISI Michael Ryskin - Bank of America Daniel Brennan - TD Cowen Rachel Vatnsdal - JP Morgan Tycho Peterson - Jefferies Luke Sergott - Barclays Patrick Donnelly - Citi Tejas Savant - Morgan Stanley Conor McNamara - RBC Capital Markets Ivy Ma - Goldman Sachs Brandon Couillard - Wells Fargo Jack Meehan - Nephron Research Operator Hello everybody and a warm welcome to Avantor's Fourth Quarter 2024 Earnings Call. My name is Emily and I'll be coordinating your call today. seekingalpha.com - 3 weeks ago
Avantor (AVTR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Avantor (AVTR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 3 weeks ago
Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025 On Friday, Avantor Inc AVTR reported fourth-quarter net sales of $1.69 billion, a decrease of 2% year-over-year, missing the consensus of $1.71 billion. benzinga.com - 3 weeks ago
Avantor, Inc. (AVTR) Surpasses Q4 Earnings Estimates Avantor, Inc. (AVTR) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago. zacks.com - 3 weeks ago
Avantor® Reports Fourth Quarter and Full Year 2024 Results Fourth Quarter 2024 Net sales of $1.69 billion, decrease of 2%; organic growth of 1% Net income of $500.4 million; Adjusted EBITDA of $307.7 million Diluted GAAP EPS of $0.73; adjusted EPS of $0.27 Operating cash flow of $173.3 million; free cash flow of $222.1 million Full Year 2024 Net sales of $6.78 billion, decrease of 3%; organic decline of 2% Net income of $711.5 million; Adjusted EBITDA of $1,198.8 million Diluted GAAP EPS of $1.04; adjusted EPS of $0.99 Operating cash flow of $840.8 million; free cash flow of $768.3 million RADNOR, Pa. , Feb. 7, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its fourth fiscal quarter and year ended December 31, 2024. prnewswire.com - 3 weeks ago
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, to expand availability of its innovative nucleic acid products to customers across Europe, Middle East, and Africa (EMEA). This distribution pa. businesswire.com - 4 weeks ago
MD vs. AVTR: Which Stock Is the Better Value Option? Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). But which of these two stocks is more attractive to value investors? zacks.com - 1 month ago
Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025 RADNOR, Pa. , Jan. 10, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and full year 2024 financial results before the market opens on Friday, February 7, and will hold a conference call to discuss the results on the same day at 8:00 a.m. prnewswire.com - 1 month ago
Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference RADNOR, Pa. , Jan. 3, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Michael Stubblefield, President and CEO, will present at the 43rd Annual J.P. prnewswire.com - 1 month ago
8. Profile Summary

Avantor, Inc. AVTR

image
COUNTRY US
INDUSTRY Chemicals - Specialty
MARKET CAP $ 11.1 B
Dividend Yield 0.00%
Description Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Contact Radnor Corporate Center, Radnor, PA, 19087 https://www.avantorsciences.com
IPO Date May 17, 2019
Employees 13500
Officers Ms. Allison K. Hosak Senior Vice President of Global Communications & Brand Mr. Christophe Couturier M.B.A Executive Vice President of AMEA Mr. Corey D. Walker President of Laboratory Solutions Mr. Claudius O. Sokenu Executive Vice President, Corporate Secretary and Chief Legal & Compliance Officer Mr. James Bramwell Executive Vice President of Sales & Customer Excellence Mr. Michael Stubblefield President, Chief Executive Officer & Director Mr. Michael Wondrasch Executive Vice President & Chief Information Officer Mr. R. Brent Jones Executive Vice President & Chief Financial Officer Mr. Steven W. Eck Senior Vice President, Corporate Controller & Chief Accounting Officer Ms. Kitty Sahin Executive Vice President of Strategy & Corporate Development